Physician
Kasper, Katherine
Kasper, Katherine was paid $332K by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 11% of everything it billed.
33Billing provider infoKASPER, KATHERINE
PEORIA, IL 61636
PEORIA, IL 61636
33aNPI1285890129assigned 07/30/2008
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$332K
24GClaims64,561
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#96 of 398
Median peer was paid$66K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,294 | $97K | |
| 2019 | 20,709 | $90K | |
| 2020 | 13,187 | $62K | |
| 2021 | 569 | $27K | |
| 2022 | 201 | $6K | |
| 2023 | 90 | $2K | |
| 2024incomplete | 8,511 | $47K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 11% | 7,399 | 6,306 | $38K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 10% | 1,030 | 982 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.2% | 9,349 | 7,308 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | 6.5% | 2,766 | 2,613 | $22K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.8% | 870 | 710 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.5% | 295 | 222 | $18K |
| 87400 | 5.4% | 2,881 | 2,686 | $18K | |
| 87430 | 4.2% | 1,813 | 1,715 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.9% | 1,938 | 1,747 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.8% | 2,218 | 1,593 | $9K |
| 84439 | 2.3% | 1,909 | 1,815 | $8K | |
| 83735 | 2.0% | 1,927 | 1,262 | $7K |
72 more codes
| 87081 | 1.9% | 2,141 | $6K | |
| 80061 | Lipid panel | 1.9% | 2,007 | $6K |
| 83690 | 1.7% | 1,728 | $6K | |
| 87807 | 1.6% | 1,068 | $5K | |
| 84484 | 1.5% | 1,064 | $5K | |
| 81001 | 1.4% | 3,767 | $5K | |
| 87186 | 1.4% | 831 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.2% | 1,243 | $4K |
| 85027 | 1.1% | 1,273 | $4K | |
| 87040 | 1.1% | 385 | $4K | |
| 81025 | 1.1% | 2,072 | $4K | |
| 82962 | <1% | 1,549 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 37 | $3K |
| 87806 | <1% | 296 | $3K | |
| 80306 | <1% | 688 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $3K |
| 85610 | <1% | 1,358 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 156 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 223 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 107 | $2K |
| 80305 | <1% | 653 | $2K | |
| 88304 | <1% | 68 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 103 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 103 | $2K |
| 85730 | <1% | 633 | $2K | |
| 88307 | <1% | 42 | $2K | |
| 84702 | <1% | 310 | $1K | |
| 83605 | <1% | 287 | $1K | |
| 86140 | <1% | 577 | $1K | |
| 86901 | <1% | 491 | $1K | |
| 80055 | <1% | 75 | $1K | |
| 86850 | <1% | 380 | $1K | |
| 83880 | <1% | 114 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 78 | $1K |
| 85007 | <1% | 584 | $1K | |
| 86900 | <1% | 492 | $961.60 | |
| 87512 | <1% | 55 | $904.83 | |
| 86803 | <1% | 113 | $838.77 | |
| 82803 | <1% | 91 | $764.97 | |
| 88142 | <1% | 211 | $695.74 | |
| 85652 | <1% | 476 | $617.63 | |
| 86308 | <1% | 236 | $573.31 | |
| 82150 | <1% | 156 | $508.89 | |
| 88342 | <1% | 13 | $336.36 | |
| 85014 | <1% | 339 | $305.05 | |
| 83550 | <1% | 65 | $273.92 | |
| 82728 | <1% | 63 | $270.92 | |
| 87205 | <1% | 139 | $270.13 | |
| 85018 | <1% | 345 | $263.51 | |
| 87481 | <1% | 12 | $246.32 | |
| 85379 | <1% | 64 | $239.30 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $225.82 |
| 82950 | <1% | 97 | $223.18 | |
| 83540 | <1% | 70 | $220.11 | |
| 85060 | <1% | 13 | $193.57 | |
| 84550 | <1% | 73 | $187.30 | |
| 81003 | <1% | 165 | $171.13 | |
| 83520 | <1% | 26 | $163.82 | |
| 87045 | <1% | 25 | $152.73 | |
| 88141 | <1% | 42 | $142.60 | |
| 86880 | <1% | 35 | $111.96 | |
| 86038 | <1% | 14 | $110.60 | |
| 87070 | <1% | 31 | $99.20 | |
| 80069 | <1% | 21 | $85.20 | |
| 82553 | <1% | 15 | $80.13 | |
| 82607 | <1% | 13 | $72.05 | |
| 83615 | <1% | 28 | $66.72 | |
| 85651 | <1% | 29 | $66.70 | |
| 84030 | <1% | 25 | $65.33 | |
| 82776 | <1% | 25 | $62.33 | |
| 82248 | <1% | 16 | $40.77 | |
| 82570 | <1% | 12 | $27.96 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.